Anticoagulation Software

 

 

Latest News

Version 7 Sampler E-Book

Why Computer Aided   Dosing is so important!

How does the Computer Manage Doses ?

What our Customers Say!

Why Buy Dawn AC?

Existing Customer List

Why Customers Chose Dawn AC

Your Key Objectives

Success Factors

Benefit/Cost Statement

Version 6 Structure

Newsletter

Audit and Benchmarking

 

E-Newsletter May 2006

Topics in this Dawn AC E-Newsletter              Previous Newsletters

Topics in this Dawn AC E-Newsletter 

New Location for the Dawn AC User Group 18th/19th September 2006

You should have received your invitation to this years user group which is in a completely new location near the picturesque Lake Ullswater. If you have not received an invitation please drop me an e-mail. Do not miss out; we have some great talks lined up for this year's User Group Meeting. Please send in your application form as soon as possible to get your "early bird" discount. Here is the provisional list of talks:

Provisional Programme so far

  • “Oral anticoagaulation in Iceland: before and after the DAWN" Dr Pall Torfi Onundarson, Consultant Haematologist, Landspitali University Hospital, Reykjavik, Iceland.

  • "Predicting Venous Thrombosis Recurrence using D-dimer"  Dr Campbell Tait, Department of Haematology, Royal Infirmary, Glasgow.

  • "Anticoagulation - the next 5 years" Dr Eric J Watts, Consultant Haematologist, Basildon & Thurrock Hospitals

  • "Converting Dawn AC v6 to V7" Richard Creamer, Pharm D, Clinical Pharmacy Supervisor, Kaiser Permanente of Colorado, USA.

  •  'Convert from Coumacare to Dawn AC V7" Theresa Hodgkins, Pharm D, Director of Anticoagulation Clinic, Desert Medical Group, Cathedral City, California, USA.

  •  "Merging two Hospitals into Dawn AC V7" Jo Nightingale, Head Biomedical Scientist, Kent & Canterbury Hospital.

  •  "A GP Perspective" Dr Philip Ikeme, Parsons Green Medical Centre, London

Please note that I am still looking for very short talks on practical tips and solutions that folks have used to help make their anticoagulation service better or on any related subject. Speakers are given a discount of £100 on the cost of the conference.

  

GP's Prescribe Interacting Drugs 

An audit of more than 300 GP's in Scotland found many patients on warfarin were also being prescribed other drugs, which could dangerously interact. NSAIDs were found in 22% of cases, while aspirin was given in 18%.

May be our only hope is to educate our patients to always tell their GP that they are taking warfain when their GP prescribes any drug.

 The full details of this study http://news.scotsman.com/scitech.cfm?id=748172006    

 84% recommend DAWN AC

Thank you for completing the DAWN AC customer survey. We had a 23% response rate and it was extremely pleasing to discover that 84% of respondents said that they would definitely recommend Dawn AC to others.

Only 30% suggested that changes could be made to improve the product, with 46% thinking that changes were not necessary.

59% of respondents said they had heard of DAWN AC through 'word of mouth,' thank you. and keep up the good work!

Syd Stewart

Managing Director

End of Newsletter

 © 2006 4S Information Systems Ltd

“We Really Care"

“Dawn AC is an easy to use, adaptable, powerful, and comprehensive PC based Anticoagulation Software System. It covers the complete oral anticoagulation life cycle with Induction and Maintenance Modules “

“Lancet Nov 7th 1998, Multi-centred Randomised Trial using Dawn AC shows computer aided dosage leads to INR control 20 to 30% better than medical experts”